The Valley Desk

ArticleJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

14 of 33 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Immunotherapy, Adoptive; Remission Induction; Adult; Aged; Middle Aged; Female; Male; Progression-Free Survival
PubMed ID
40459151
PubMed Central ID
PMC12393059
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal